XTL Biopharma (XTLB) Reports Q2 Loss of $0.002/Share

XTL Biopharma (NASDAQ: XTLB) reported Q2 EPS of $-0.002, versus $-0.001 reported last year.

For earnings history and earnings-related data on XTL Biopharma (XTLB) click here.

You May Also Be Interested In

• Rivian reports record Q3 deliveries, beats estimates, shares rise
• Cantor Fitzgerald on Rivian (RIVN): 'pre-announced that it delivered 19,248 vehicles in 3Q26, above our estimate'
• Rivian reports Q3 2026 production of 19,751 vehicles